FK506-Binding Protein 11 Is a Novel Plasma Cell-Specific Antibody Folding Catalyst with Increased Expression in Idiopathic Pulmonary Fibrosis
Authors:
- Stefan PreisendörferSPStefan Preisendörfer
- Yoshihiro IshikawaYIYoshihiro Ishikawa
- Elisabeth HennenEHElisabeth Hennen
- Stephan WinklmeierSWStephan Winklmeier
- Jonas C. SchuppJSJonas C. Schupp
- Larissa KnüppelLKLarissa Knüppel
- Isis E. FernandezIFIsis E. Fernandez
- Leonhard BinzenhöferLBLeonhard Binzenhöfer
- Andrew FlatleyAFAndrew Flatley
- Brenda M. Juan-GuardelaBJBrenda M. Juan-Guardela
- Clemens RuppertCRClemens Ruppert
- Andreas GuentherAGAndreas Guenther
Open Access
Abstract
Antibodies are central effectors of the adaptive immune response, widespread used therapeutics, but also potentially disease-causing biomolecules. Antibody folding catalysts in the plasma cell are incompletely defined. Idiopathic pulmonary fibrosis (IPF) is a fatal chronic lung disease with increasingly recognized autoimmune features. We found elevated expression of FK506-binding protein 11 (FKBP11) in IPF lungs where FKBP11 specifically localized to antibody-producing plasma cells. Suggesting a general role in plasma cells, plasma cell-specific FKBP11 expression was equally observed in lymphatic tissues, and in vitro B cell to plasma cell differentiation was accompanied by induction of FKBP11 expression. Recombinant human FKBP11 was able to refold IgG antibody in vitro and inhibited by FK506, strongly supporting a function as antibody peptidyl-prolyl cis-trans isomerase. Induction of ER stress in cell lines demonstrated induction of FKBP11 in the context of the unfolded protein response in an X-box-binding protein 1 (XBP1)-dependent manner. While deficiency of FKBP11 increased susceptibility to ER stress-mediated cell death in an alveolar epithelial cell line, FKBP11 knockdown in an antibody-producing hybridoma cell line neither induced cell death nor decreased expression or secretion of IgG antibody. Similarly, antibody secretion by the same hybridoma cell line was not affected by knockdown of the established antibody peptidyl-prolyl isomerase cyclophilin B. The results are consistent with FKBP11 as a novel XBP1-regulated antibody peptidyl-prolyl cis-trans isomerase and indicate significant redundancy in the ER-resident folding machinery of antibody-producing hybridoma cells.Keywords
Funding Information
- Friedrich-Baur-Stiftung (51/16)
- the Helmholtz Association, the German Center for Lung Research (DZL), the Deutsche Forschungsgemeinschaft (DFG) within the Research Training Group (GRK2338)
- National Institutes of Health (RO1HL108642, RC2HL101715, U54 AG075931, R01 HL146519)
- Shriners Hospital for Children (to H.P.B)
- The CPC Research School (funded S.P.’s stay in the H.P.B. lab)
- Deutsche Forschungsgemeinschaft (SFB-TR128)
- Else Kröner-Fresenius Foundation (2021_EKEA.16)
This publication has 88 references indexed in Scilit:
- Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary FibrosisPLOS ONE, 2013
- Role of S-Palmitoylation on IFITM5 for the Interaction with FKBP11 in Osteoblast CellsPLOS ONE, 2013
- The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary FibrosisPLOS ONE, 2011
- Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cellsHaematologica, 2010
- Origin and evolution of the adaptive immune system: genetic events and selective pressuresNature Reviews Genetics, 2009
- XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell developmentJournal of Experimental Medicine, 2009
- An Unfolded CH1 Domain Controls the Assembly and Secretion of IgG AntibodiesMolecular Cell, 2009
- Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced SclerodermaThe American Journal of Pathology, 2008
- Fibrillin-1: Organization in Microfibrils and Structural PropertiesJournal of Molecular Biology, 1996